|
|
||||||||


*
Laboratory of Mammalian Genes & Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892; and
Division of Therapeutic Proteins, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892
Whether a developing thymocyte becomes positively or negatively
selected is thought to be determined by the affinity/avidity of its TCR
for MHC/peptide ligands expressed in the thymus. Presumably,
differences in affinity translate into differences in the potency of
the ensuing TCR-mediated signals, and these differences in signal
strength determine the outcome of thymocyte selection. However, there
is little direct evidence establishing a relationship between
TCR-ligand affinity and signal strength during positive and negative
selection. The TCR complex contains multiple signaling motifs, known as
immunoreceptor tyrosine-based activation motifs (ITAMs) that are
required for T cell activation. To examine the effects of TCR signal
strength on selection, the signaling potential of the TCR was modified
by substituting transgenic TCR
-chains containing either three, one,
or zero ITAMs for endogenous (3-ITAM)
-chain. These
-chain
variants were then bred into different
ßTCR transgenic
backgrounds. We report that reductions in TCR signaling potential have
distinct effects on the selection of thymocytes expressing different
TCRs, and that the requirement for
-chain ITAMs critically depends
upon the specificity and apparently, affinity, of the TCR for its
selecting ligand(s).
This article has been cited by other articles:
![]() |
M. E. Keir, Y. E. Latchman, G. J. Freeman, and A. H. Sharpe Programmed Death-1 (PD-1):PD-Ligand 1 Interactions Inhibit TCR-Mediated Positive Selection of Thymocytes J. Immunol., December 1, 2005; 175(11): 7372 - 7379. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Pitcher, M. A. Mathis, S. Subramanian, J. A. Young, E. K. Wakeland, P. E. Love, and N. S. C. van Oers Selective Expression of the 21-Kilodalton Tyrosine-Phosphorylated Form of TCR {zeta} Promotes the Emergence of T Cells with Autoreactive Potential J. Immunol., May 15, 2005; 174(10): 6071 - 6079. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Pitcher, P. S. Ohashi, and N. S. C. van Oers T Cell Antagonism is Functionally Uncoupled from the 21- and 23-kDa Tyrosine-Phosphorylated TCR {zeta} Subunits J. Immunol., July 15, 2003; 171(2): 845 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Lucas, L. O. Atherly, and L. J. Berg The Absence of Itk Inhibits Positive Selection Without Changing Lineage Commitment J. Immunol., June 15, 2002; 168(12): 6142 - 6151. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Spain and P. Liu TCR{beta} Transmembrane Tyrosines Are Required for Pre-TCR Function J. Immunol., January 1, 2002; 168(1): 127 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Magnan, V. Di Bartolo, A.-M. Mura, C. Boyer, M. Richelme, Y.-L. Lin, A. Roure, A. Gillet, C. Arrieumerlou, O. Acuto, et al. T Cell Development and T Cell Responses in Mice with Mutations Affecting Tyrosines 292 or 315 of the ZAP-70 Protein Tyrosine Kinase J. Exp. Med., August 20, 2001; 194(4): 491 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Azzam, J. B. DeJarnette, K. Huang, R. Emmons, C.-S. Park, C. L. Sommers, D. El-Khoury, E. W. Shores, and P. E. Love Fine Tuning of TCR Signaling by CD5 J. Immunol., May 1, 2001; 166(9): 5464 - 5472. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |